We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a statement, Bayer said that after reviewing the data for eliapixant (formerly BAY1817080 ) it had concluded that "the overall benefit no long outweighs the risk" in the drug's four target ...

European Union leaders said on Thursday that they will continue to support Ukraine, but they did not immediately endorse a call by Ukrainian President Volodymyr Zelenskiy to provide at least 5 ...

Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA ...